Search

everythinglearnresearchcommunity

for

Search:↓

T cells and bacteria in the gut and skin help maintain health and protect against disease.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Skin bacteria can help wound healing by activating certain immune cells.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Regulatory T cells are essential for normal and improved wound healing in mice.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

New treatments for lupus show promise, but more research is needed, especially for children.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Tertiary lymphoid structures are important in immunotherapy and need more research.

Certain drugs may cause vitiligo, so patients should be monitored.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.